Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.

Merdad A, Karim S, Schulten HJ, Dallol A, Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM, Al-Qahtani MH.

Anticancer Res. 2014 Mar;34(3):1355-66.

PMID:
24596383
2.

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.

Köhrmann A, Kammerer U, Kapp M, Dietl J, Anacker J.

BMC Cancer. 2009 Jun 16;9:188. doi: 10.1186/1471-2407-9-188.

3.

Expression of matrix metalloproteinases in human breast cancer tissues.

Benson CS, Babu SD, Radhakrishna S, Selvamurugan N, Ravi Sankar B.

Dis Markers. 2013;34(6):395-405. doi: 10.3233/DMA-130986.

4.

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.

BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.

5.
6.

Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.

Katchman BA, Ocal IT, Cunliffe HE, Chang YH, Hostetter G, Watanabe A, LoBello J, Lake DF.

Breast Cancer Res. 2013 Mar 28;15(2):R28. doi: 10.1186/bcr3407.

7.

Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.

Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE.

Int J Mol Med. 2006 Apr;17(4):583-90.

PMID:
16525713
8.
9.

Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.

Kawakami K, Enokida H, Tachiwada T, Gotanda T, Tsuneyoshi K, Kubo H, Nishiyama K, Takiguchi M, Nakagawa M, Seki N.

Oncol Rep. 2006 Sep;16(3):521-31.

PMID:
16865252
10.

Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.

Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y.

BMC Cancer. 2010 Aug 10;10:414. doi: 10.1186/1471-2407-10-414.

11.

TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.

Gomes LR, Terra LF, Wailemann RA, Labriola L, Sogayar MC.

BMC Cancer. 2012 Jan 19;12:26. doi: 10.1186/1471-2407-12-26.

12.

Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.

Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R.

Clin Cancer Res. 2004 Nov 1;10(21):7335-46.

13.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
14.

Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.

Eiseler T, Döppler H, Yan IK, Goodison S, Storz P.

Breast Cancer Res. 2009;11(1):R13. doi: 10.1186/bcr2232. Epub 2009 Feb 25.

15.

The value of MMP-9 for breast and non-small cell lung cancer patients' survival.

Schveigert D, Cicenas S, Bruzas S, Samalavicius NE, Gudleviciene Z, Didziapetriene J.

Adv Med Sci. 2013;58(1):73-82. doi: 10.2478/v10039-012-0066-y.

PMID:
23640949
16.

Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.

Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, Ajarim D, Adra C.

PLoS One. 2011;6(11):e27339. doi: 10.1371/journal.pone.0027339. Epub 2011 Nov 4.

17.
18.

Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.

Hancox RA, Allen MD, Holliday DL, Edwards DR, Pennington CJ, Guttery DS, Shaw JA, Walker RA, Pringle JH, Jones JL.

Breast Cancer Res. 2009;11(2):R24. doi: 10.1186/bcr2251. Epub 2009 Apr 30.

19.

Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.

Giantin M, Aresu L, Benali S, Aricò A, Morello EM, Martano M, Vascellari M, Castagnaro M, Lopparelli RM, Zancanella V, Granato A, Mutinelli F, Dacasto M.

J Comp Pathol. 2012 Nov;147(4):419-29. doi: 10.1016/j.jcpa.2012.01.011. Epub 2012 Apr 19.

PMID:
22520817
20.

Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.

O-Charoenrat P, Rhys-Evans PH, Eccles SA.

Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20.

PMID:
11448356

Supplemental Content

Support Center